Heart disease remains a leading cause of death worldwide. Owing to the limited regenerative capacity of heart tissue, cardiac regenerative therapy has emerged as an attractive approach. Direct reprogramming of human cardiac fibroblasts (HCFs) into cardiomyocytes may hold great potential for this purpose. We reported previously that induced cardiomyocyte-like cells (iCMs) can be directly generated from mouse cardiac fibroblasts in vitro and vivo by transduction of three transcription factors: Gata4, Mef2c, and Tbx5, collectively termed GMT. In the present study, we sought to determine whether human fibroblasts also could be converted to iCMs by defined factors. Our initial finding that GMT was not sufficient for cardiac induction in HCFs prompted us to screen for additional factors to promote cardiac reprogramming by analyzing multiple cardiac-specific gene induction with quantitative RT-PCR. The addition of Mesp1 and Myocd to GMT up-regulated a broader spectrum of cardiac genes in HCFs more efficiently compared with GMT alone. The HCFs and human dermal fibroblasts transduced with GMT, Mesp1, and Myocd (GMTMM) changed the cell morphology from a spindle shape to a rod-like or polygonal shape, expressed multiple cardiac-specific proteins, increased a broad range of cardiac genes and concomitantly suppressed fibroblast genes, and exhibited spontaneous Ca 2+ oscillations. Moreover, the cells matured to exhibit action potentials and contract synchronously in coculture with murine cardiomyocytes. A 5-ethynyl-2′-deoxyuridine assay revealed that the iCMs thus generated do not pass through a mitotic cell state. These findings demonstrate that human fibroblasts can be directly converted to iCMs by defined factors, which may facilitate future applications in regenerative medicine.
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cell fate conversion | regeneration | cardiogenesis C ardiovascular disease remains a leading cause of death worldwide, for which current therapeutic regimens remain limited. Given that adult human hearts have little regenerative capacity after injury, the demand is high for cardiac regenerative therapy. The recent discovery of induced pluripotent stem cells (iPSCs) allows the direct generation of specific cell types from differentiated somatic cells by overexpression of lineagespecific factors.
Several previous studies have demonstrated that such direct lineage reprogramming can yield a diverse range of cell types, including pancreatic β cells, neurons, neural progenitors, blood progenitors, and hepatocyte-like cells (1) (2) (3) (4) (5) . We previously reported that a minimum mixture of three cardiac-specific transcription factors-Gata4, Mef2c, and Tbx5 (GMT)-directly induced cardiomyocyte-like cells (iCMs) from mouse fibroblasts in vitro (6) . Following our report, three other groups also reported generation of functional cardiomyocytes from mouse fibroblasts with various combinations of transcription factors, either with GMT plus Hand2 (GHMT) or Mef2c, Myocd, and Tbx5 or using microRNAs (7) (8) (9) . Although full reprogramming into beating cardiomyocytes was not efficient in vitro (10, 11) , gene transfer of GMT or GHMT into mouse hearts generated new cardiomyocytes from endogenous cardiac fibroblasts and improved cardiac function after myocardial infarction (7, 12, 13) . The foregoing studies suggest that direct cardiac reprogramming may be a useful therapeutic approach for regenerative purposes, and that identification of reprogramming factors in human cells is important for the development of this technology (14) (15) (16) .
In the present study, we sought to generate cardiomyocytes directly from postnatal human fibroblasts. We found that GMT was not sufficient for cardiac reprogramming in human cells. We then screened additional reprogramming factors for their ability to induce cardiac reprogramming by analyzing multiple cardiac gene induction, and found that the addition of Mesp1 and Myocd to GMT was able to generate cardiomyocyte-like cells from human fibroblasts in vitro.
Results
Gata4, Mef2c, Tbx5, Mesp1, and Myocd Induce Multiple Cardiac Gene Expression in Human Cardiac Fibroblasts. We first developed a culture system for human cardiac fibroblasts (HCFs) following our mouse cardiac fibroblast isolation protocol. Human atrial tissues were obtained from 36 patients (age 1 mo to 80 y; average age, 35 y) undergoing cardiac surgery with informed consent following the guidelines of the Keio University Ethics Committee. The Thy1 + /CD31 -FACS-sorted fibroblasts did not express cardiomyocyte or cardiac progenitor cell (CPC) genes, but did express fibroblast genes on quantitative RT-PCR (qRT-PCR) analysis (Fig. S1 A-C) . HCFs expressed fibroblast proteins, vimentin, and fibronectin, but not markers of cardiomyocytes, CPCs, smooth muscle cells, or endothelial cells (Fig. 1A and Fig. S1D ). The antibody immunoreactivities were confirmed in the positive controls (Fig. S1E) . FACS analyses also demonstrated that the HCF population did not contaminate cardiomyocytes (Fig. 1B) .
For transduction, we first used the sequential lentivirus/ecotropic retrovirus infection following the iPSC generation protocol from human dermal fibroblasts (HDFs) (17) . The transduction efficiency was <20% in HCFs (Fig. 1C) . We then directly infected HCFs using other types of retroviruses, produced by PLAT-A cells and PLAT-GP cells (18) . We achieved high transduction efficiency (>90%) using the pantropic retrovirus from PLAT-GP cells, and used this virus in subsequent experiments ( Fig. 1 C-E) .
We next transduced HCFs with a mixture of GMT retroviruses. The GMT overexpression induced very few α-actinin + cells, suggesting that this mixture is insufficient for human cardiac reprogramming ( Fig. 2A) . To identify reprogramming factors, we screened an additional 11 factors for use in combination with GMT and analyzed the induction of multiple cardiac genes by qRT-PCR after 1 wk of transduction. Of these 11 factors, only Myocd strongly induced Tnnt2 expression (Fig. 1F) . Myocd also induced Nppa, but did not induce Ryr2 (ryanodine receptor 2). In contrast, Mesp1, Nkx2.5, and Pitx2c strongly induced Ryr2 expression ( Fig. 1 G and H) .
Consistent with our qRT-PCR results, FACS analysis and immunocytochemistry demonstrated that the addition of Myocd to GMT increased the expression of sarcomere proteins α-actinin and cTnT in HCFs compared with Mesp1. In contrast, threefold more cells exhibited spontaneous Ca 2+ oscillations by transduction of GMTMesp1 compared with GMTMyocd after 4 wk of culture (Fig. S2 A-E and Movie S1).
We next investigated whether the addition of Mesp1, Nkx2.5, or Pitx2c to GMT and Myocd could induce multiple cardiac gene expression. We found that Nkx2.5 and Pitx2c inhibited Tnnt2 mRNA expression, but that addition of Mesp1 up-regulated all three cardiac genes ( Fig. 1 I-K) . Moreover, transduction of Gata4, Mef2c, Tbx5, Mesp1, and Myocd (GMTMM) up-regulated the expression of a panel of cardiac genes related to different functions, including sarcomere structure, ion channels, and transcription factors, compared with GMT or mock infection, suggesting a more comprehensive reprogramming by GMTMM than by GMT (Fig. 1L) . Gata4, Mef2c, Tbx5, Mesp1, and Myocd Induce Cardiac-Specific Proteins and Sarcomeric Structures in HCFs. We next used immunocytochemistry to examine whether cardiac proteins were expressed in HCFs by GMTMM. We found that more GMTMM-transduced HCFs (GMTMM-HCFs) expressed α-actinin with higher intensity compared with GMT, and that the α-actinin + cells had sarcomerelike structures after 4 wk of culture ( Fig. 2A) . Morphologically, mock-infected HCFs were spindle-shaped, whereas GMTMMHCFs appeared thicker and refractive on phase-contrast microscopy, with a polygonal or rod-like shape (Fig. 2B) . FACS analysis demonstrated that approximately 5% of the GMTMM-HCFs expressed the endogenous cardiac proteins α-actinin and cTnT (Fig.  2C) . In addition to α-actinin, the GMTMM-HCFs expressed several cardiomyocyte-specific proteins, including atrial natriuretic peptide (ANP), cTnT, cTnI, and connexin 43 (Cx43), at similar levels as those in the human ES cell-derived cardiomyocytes (HESC-CMs) (Fig. 2 D-G and Figs. S1E and S2F ). Approximately 40% of α-actinin + cells expressed ANP, and most cTnT + cells expressed cTnI, another cardiomyocyte-specific sarcomere protein (Fig. 2 D-G) . The addition of Nkx2.5 reduced cTnT expression, confirming the qRT-PCR results (Fig. 1I and Fig. S2G ). These findings suggest that GMTMM induces multiple cardiac proteins and cardiomyocyte-like structures in HCFs.
GMTMM Up-Regulates a Broad Range of Cardiac Genes and Suppresses
Fibroblast Gene Expression. Next, to decipher the global transcriptional changes induced by GMTMM transduction, we investigated the gene expression profiles of HCFs, GMTMM-HCFs, and hearts by microarray analyses. We analyzed the mRNA expression of GMTMM-HCFs after 1 wk of infection at the early reprogramming stage, because we were not able to isolate human iCM populations from GMTMM-HCFs, and the percentage of iCMs relative to the total number of GMTMM-HCFs decreased over time owing to their loss of proliferative capacity. Among the 24,462 genes analyzed, 1,432 genes were differentially expressed by more than twofold between HCFs and GMTMM-HCFs, with 1,018 genes up-regulated and 414 genes down-regulated in GMTMMHCFs (Fig. 3A) . The genes up-regulated in GMTMM-HCFs were significantly enriched in hearts compared with HCFs (P = 1.6E-86) and, conversely, the down-regulated genes were enriched in fibroblasts (P = 4.7E-67) (Fig. 3B) .
Gene Ontology (GO) analyses demonstrated that the genes up-regulated in GMTMM-HCFs were enriched related to cardiomyocyte functions, whereas the down-regulated genes were enriched for fibroblast functions, including cell division, mitotic cell cycle, cell proliferation, and cell adhesion (Fig. 3C) . Heatmap and qRT-PCR analyses of a panel of cardiac and fibroblast genes in HCFs, GMTMM-HCFs, and hearts revealed that GMTMM up-regulated cardiac genes and concomitantly suppressed fibroblast gene expression (Fig. 3 D and E) .
GMTMM Directly Induces Cardiomyocyte-Like Cells from Fibroblasts.
We next asked whether GMTMM also could induce smooth muscle cells or endothelial cells from fibroblasts. Microarray and qRT-PCR analyses revealed induction of smooth muscle genes, but not endothelial cell genes, in GMTMM-HCFs (Fig. 4 A and  B) . Consistent with this finding, immunostaining demonstrated that CD31 was not expressed in GMTMM-HCFs, whereas calponin and smooth muscle myosin heavy chain (SMMHC), markers for smooth muscle cells, and α-smooth muscle actin (α-SMA), a marker of smooth muscles and embryonic cardiomyocytes (19) , were induced by GMTMM transduction (Fig. 4 C and D and Fig.  S3A ). Coimmunostaining revealed that α-actinin + cells expressed α-SMA but not SMMHC, suggesting that the iCMs were relatively immature cardiomyocytes without a mixed phenotype between cardiomyocytes and smooth muscle cells (Fig. 4 E-G) .
We next examined the reprogramming kinetics by analyzing the cardiomyocyte and smooth muscle cell gene induction by qRT-PCR. The cardiomyocyte-specific genes Actc1, Nppa, Ryr2, and Tnnt2 and smooth muscle-specific gene Myh11 were upregulated from 4 d and subsequently down-regulated at 28 d by GMTMM, because these reprogrammed myocytes were not proliferative (Fig. 4H) . We then performed 5-ethynyl-2′-deoxyuridine (EdU) incorporation assays to determine whether the conversion of fibroblasts to cardiomyocyte-like and smooth muscle-like cells is mediated through a mitotic cell state. A 2-hr pulse labeling of EdU after 4 or 24 h of transduction demonstrated significantly reduced cell proliferation in the GMTMM-HCFs, consistent with the GO term analysis results (Fig. S3 B-D) . Long-term pulse labeling of EdU throughout a 4-wk culture period demonstrated that a vast majority of α-actinin + and SMMHC + cells did not express EdU. These results suggest that most induced cardiac and smooth muscle cells do not pass through a mitotic cell state and start to express cardiac or smooth muscle genes from the early stage of reprogramming (Fig. 4 I-K) . at a lower frequency compared with HESC-CMs (Fig. 5 A-D and Movies S2 and S3). Despite longer periods of culture, the GMTMM-HCFs did not beat spontaneously. Consequently, we next tested whether coculture with murine cardiomyocytes could induce further cardiac maturation. We transduced HCFs with GMTMM and GFP by separate vectors or GFP alone to mark the transduced cells, and after 1 wk of transduction, replated the cells onto neonatal rat cardiomyocytes. We found expression of cardiac markers, such as α-actinin, cTnT, and Cx43, in the GMTMM/GFP-HCFs, but not in the GFP-HCFs (Fig. 5E and Fig.  S4 A-C). fusion was unlikely for cardiac differentiation in the coculture (Fig. 5K, Fig. S4D , and Movies S5 and S6).
Induction of Human Cardiomyocyte-Like Cells from Dermal Fibroblasts.
To exclude the possibility of contamination with rare CPCs or cardiomyocytes in our initial fibroblast populations, we tested whether HDFs also could be converted into iCMs by GMTMM. Neonatal foreskin dermal fibroblasts transduced with GMTMM expressed α-actinin, cTnT, and ANP and showed sarcomeric structures ( Fig. 6 A and B) . FACS analysis revealed that most HDFs were Thy1 + /CD31 -fibroblasts, which also expressed cardiac genes after GMTMM transduction (Fig. S5 A and B) . GMTMMHDFs expressed cardiac-specific genes at levels comparable to GMTMM-HCFs on qRT-PCR analysis (Fig. 6C) . Microarray analyses of HDFs, GMTMM-HDFs, and hearts demonstrated that the up-regulated genes in the GMTMM-HDFs were cardiacenriched genes (P = 1.2E-21) and the down-regulated genes were fibroblast-enriched genes (P = 1.5E-74) (Fig. 6D and Fig. S5C ). The top five GO categories enriched in the up-regulated genes included muscle contraction and muscle filament sliding (Fig.  S5D) . A panel of cardiac-specific genes, including Actc1, Tnnc1, Nppa, Nppb, Myl7, Pln (phospholamban), and Ckm, were upregulated, whereas fibroblast genes Col3a1, Col6a3, Col16a1, Ecm2, Ptn, and Tnc were down-regulated in GMTMM-HDFs (Fig. 6E) . We also observed that some GMTMM-HDFs exhibited cellular contraction and APs in coculture with murine cardiomyocytes (n = 6, nodal/atrial/ventricular type = 0/2/4) (Fig. 6 F, G, and K; Fig. S5 E and F; and Movie S7). These results exclude the possibility that the iCMs arose from contaminating cardiomyocytes or CPCs in initial fibroblast populations.
We next used a doxycycline-inducible system to assess the requirement for exogenous reprogramming factors in maintaining a cardiac phenotype in iCMs. We found that transduction efficiency was ∼70%, and that transgene expression was instantly diminished by withdrawal of doxycycline, with complete loss after 10 d (Fig. S5G) . Expression of GMTMM for 5 wk induced α-actinin and cTnT expression in HCFs (Fig. 6H and Fig. S5H ). We then withdrew doxycycline after 1 wk, 10 d, or 2 wk of induction, and cultured the cells for 3 wk without doxycycline. Doxycycline removal after 1 wk and 10 d did not induce cardiac reprogramming, whereas 2 wk of induction maintained endogenous α-actinin and cTnT expression in the iCMs, and the cells exhibited APs in coculture with murine cardiomyocytes (n = 7; 0 nodal type, 7 atrial type, 0 ventricular type) (Fig. 6  H-K and Fig. S5I ). These results suggest that the fibroblasts were stably converted into cardiomyocyte-like cells after 2 wk of GMTMM transduction.
Discussion
Here we demonstrate that human fibroblasts can be directly converted to cardiomyocyte-like cells by overexpression of defined factors. We found that a pantropic retrovirus was more efficient for transduction into HCFs compared with amphotropic or lentivirus/ecotropic retrovirus systems. Given that high transduction efficiency is critical for reprogramming, the pantropic retrovirus might be widely useful for direct reprogramming from difficult-to-infect cells (11) .
Compared with mouse counterparts, induction of human iCMs required two additional factors, Mesp1 and Myocd. Generation of human iPSCs and neuronal cells also required different culture conditions or other transcription factors in addition to the mouse reprogramming factors (21, 22) . Mesp1 is expressed in CPCs and programs nascent mesoderm toward a cardiovascular cell fate, whereas Myocd regulates the development of cardiomyocytes and smooth muscle cells (23) (24) (25) . Islas et al. (26) recently reported that overexpression of Ets2 and Mesp1 reprogrammed HDFs into CPCs, and that the induced CPCs differentiated into immature cardiomyocytes. Mesp1 overexpression activated some of the core cardiac transcription factors but failed to convert fibroblasts to CPCs. Given that their induced CPCs were highly replicative cells, the route of cardiac induction by Ets2/Mesp1 differed from that by GMTMM. More recently, Nam et al. (27) reported that overexpression of Gata4, Hand2, Tbx5, Myocd, miR-1, and miR-133 reprogrammed human fibroblasts into cardiac-like myocytes. Consistent with our results, they also found that neither of the mouse reprogramming factors GHMT or GMT was sufficient for cardiac reprogramming in human fibroblasts, and that the addition of Myocd significantly increased the expression of cardiac sarcomeric proteins. In addition, they reported that Hand2 was critical for inducing tropomyosin and cTnT in HDFs, and that the addition of miR-1 and 133 further improved cardiac reprogramming and eliminated the requirement for Mef2c.
In their study, by transduction using the six factors, 13% of adult HCFs expressed cTnT and a small subset of the cells exhibited spontaneous contractions after 11 wk of culture, suggesting greater reprogramming efficiency than with GMTMM. However, the functional properties of the induced cardiac-like myocytes remain unclear, and further investigation may be needed to clarify this point. Myocd overexpression induces smooth muscle cells from fibroblasts by forming transcriptional complexes with Srf and promotes cardiomyocyte differentiation by interacting with Gata4 and Tbx5 (28) (29) (30) . Stoichiometry of transcription factors might determine the cell fate of GMTMMtransduced cells to iCMs or smooth muscle-like cells in our study. As demonstrated by the fact that addition of Myocd upregulated sarcomeric genes and Mesp1 induced intracellular Ca 2+ oscillations, Myocd and Mesp1 differentially regulate cardiac gene expression in human cardiac reprogramming.
The human iCMs generated by GMTMM seem to be relatively immature cardiomyocytes, as indicated by their cell morphology, expression of embryonic cardiomyocyte marker α-SMA, and slow Ca 2+ oscillations. Compared with mouse iCMs, human iCMs require coculture with murine cardiomyocytes to differentiate into beating cardiomyocytes. In this sense, the human iCMs may be similar to the early stage of embryonic cardiomyocytes before the start of contraction. Alternatively, the cells might be partially reprogrammed cardiomyocytes, much like the pre-iPSCs that can become fully pluripotent with additional stimuli.
Although the iCMs expressed a panel of cardiac-specific genes, their similarity of human iCMs to bona fide cardiomyocytes remained unclear. To address this question, we attempted to FACSsort iCM populations using a fluorescent dye that labels mitochondria to selectively mark cardiomyocytes in ESC culture (31); however, we could not use this dye owing to the abundant labeling of mitochondria in the nonconverted HCF population. Further study is needed to thoroughly optimize conditions for human iCM generation and maturation and characterize the properties of iCMs.
It is possible that the immature iCM phenotypes could reflect the low percentage of iCMs and low cell-cell contact in the heterogeneous culture, and that enrichment of iCMs may enhance cardiac reprogramming. Given that secreted proteins, electrical and mechanical stimulation, and cell-cell contact might promote cardiac differentiation and reprogramming in the coculture, the in vitro system might represent a valuable platform for screening such key factors. From a practical standpoint, GMTMM may be sufficient human cardiac reprogramming factors, considering that the in vivo environment might be more permissive than culture dishes for reprogramming (7, 13) . Further in vitro and in vivo studies are needed to facilitate application of this technology in potential regenerative therapies.
Materials and Methods
Human atrial tissues were obtained from 36 patients undergoing cardiac surgery (age 1 mo to 80 y; average age, 35 y) with informed consent in conformation with the guidelines of the Keio University Ethics Committee. HCFs were obtained following the mouse protocol as detailed in SI Materials and Methods. Human neonatal foreskin dermal fibroblasts (DS Pharma Biomedical) were cultured in DMEM containing 10% FBS. All experiments were performed using fibroblasts of early passage number (P1-P3). The Keio Centre for Clinical Research approved all of the experiments in this study (20100131) . Isolation of human fibroblasts, cell culture, retroviral and lentiviral infection, FACS analysis, immunocytochemistry, qRT-PCR, DNA microarray, calcium imaging, and patch clamp electrophysiology are described in SI Materials and Methods.
Note Added in Proof. Nam et al. (27) reported that overexpression of Gata4, Hand2, Tbx5, Myocd, miR-1, and miR-133 reprogrammed human fibroblasts into cardiac-like myocytes. We found that a different combination of cardiac reprogramming factors-Gata4, Mef2c, Tbx5, Mesp1, and Myocd-also reprogrammed human fibroblasts into cardiomyocyte-like cells. Our induced cardiomyocytes did not beat spontaneously, but matured to exhibit action potentials and contract synchronously in coculture with murine cardiomyocytes.
